Related Experiment Video
Updated: Aug 9, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Managing risk factors for atherosclerosis in critical limb ischaemia
1University of Lund, Department of Vascular Diseases, Malmö University Hospital, S-205 02 Malmö, Sweden. anders.gottsater@skane.se
Insights
Critical limb ischaemia (CLI) management requires addressing key risk factors like diabetes and hypertension. Treatment should follow guidelines for other atherosclerotic conditions due to limited specific research on CLI.
Area of Science:
- Vascular Medicine
- Cardiovascular Research
- Public Health
Background:
- Critical limb ischaemia (CLI) is a severe manifestation of peripheral artery disease.
- CLI carries a high mortality rate, with 1-year and 10-year mortality approximately 20% and 75%, respectively.
- Risk factors for CLI overlap significantly with those for coronary and cerebrovascular atherosclerosis.
Purpose of the Study:
- To review the optimal medical management strategies for critical limb ischaemia (CLI).
- To identify and discuss the primary risk factors associated with CLI development.
- To provide evidence-based recommendations for CLI treatment in the absence of extensive CLI-specific studies.
Main Methods:
- A comprehensive literature search was conducted using PubMed.
- Studies focusing on critical limb ischaemia (CLI) and its associated risk factors were included.
- Analysis of published data to synthesize current understanding and management approaches.
Main Results:
- Key risk factors for peripheral atherosclerosis include diabetes mellitus, hyperlipidaemia, arterial hypertension, and smoking.
- Limited specific research exists for risk factors in peripheral arterial occlusive disease (PAOD).
- Treatment recommendations for CLI are often extrapolated from studies on coronary and cerebrovascular atherosclerosis.
Conclusions:
- CLI patients face substantial short-term and long-term mortality risks.
- Effective management of modifiable risk factors is crucial for CLI patients.
- Current treatment guidelines for other atherosclerotic diseases should be applied to CLI patients pending further specific research.
Objective:
To review the best medical management of critical limb ischaemia (CLI).
Methods:
Published studies dealing with CLI and risk factors were searched for via PUBMED.
Findings And Conclusions:
Patients with critical limb ischaemia (CLI) have a one and ten year mortality of approximately 20% and 75% respectively. Risk factors for the development of peripheral atherosclerosis are the same as for coronary and cerebrovascular atherosclerosis namely diabetes mellitus, hyperlipidaemia, arterial hypertension, and smoking. As there are few studies of risk factor for peripheral arterial occlusive disease (PAOD), treatment recommendations are often based on studies in patients with coronary or cerebrovascular atherosclerosis. While waiting for specific studies, CLI patients should be treated according to current guidelines for other atherosclerotic patients.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease IV: Nursing Management